SING GEORGE L — SEC Form 4 filings
SEC reporting owner CIK 1225471. 8 Form 4 filings on record with FilingPulse; latest filed 2026-01-06.
Transaction summary — filings shown
Covers all 8 filings on record, filed 2024-02-12 to 2026-01-06. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 8 legs across 3 filings — 5,500 shares, $5,330,000 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 27.
- Largest priced transaction: sale of 1,000 shares @ $970.00 ($970,000) in REGENERON PHARMACEUTICALS, INC., filed 2024-02-26.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| REGENERON PHARMACEUTICALS, INC. (REGN) | Director | 8 | — | 8 legs · 5,500 sh · $5,330,000 | 27 |
Form 4 filings — SING GEORGE L
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-01-06 | 4 | REGENERON PHARMACEUTICALS, INC. (REGN) | Grant/award (A): 155 @ $0 · Grant/award (A): 1,962 (derivative) @ $0 | EDGAR |
| 2025-12-31 | 4 | REGENERON PHARMACEUTICALS, INC. (REGN) | Option exercise (M): 9,212 @ $520.01 · Tax withholding (F): 6,188 @ $774.03 · Option exercise (M): 9,212 (derivative) @ $0 | EDGAR |
| 2025-01-03 | 4 | REGENERON PHARMACEUTICALS, INC. (REGN) | Option exercise (M): 3,338 @ $413.33 · Tax withholding (F): 1,948 @ $708.19 · Grant/award (A): 166 @ $0 · Option exercise (M): 3,338 (derivative) @ $0 · Grant/award (A): 1,958 (derivative) @ $0 | EDGAR |
| 2024-09-05 | 4 | REGENERON PHARMACEUTICALS, INC. (REGN) | Gift (G): 1,200 @ $0 | EDGAR |
| 2024-05-06 | 4 | REGENERON PHARMACEUTICALS, INC. (REGN) | Option exercise (M): 2,000 @ $413.33 · Tax withholding (F): 877 @ $942.53 · Option exercise (M): 2,000 (derivative) @ $0 | EDGAR |
| 2024-02-28 | 4 | REGENERON PHARMACEUTICALS, INC. (REGN) | Option exercise (M): 500 @ $413.33 · Sale (S): 500 @ $990 · Option exercise (M): 500 @ $413.33 · Sale (S): 500 @ $995 · Option exercise (M): 1,000 (derivative) @ $0 | EDGAR |
| 2024-02-26 | 4 | REGENERON PHARMACEUTICALS, INC. (REGN) | Option exercise (M): 1,000 @ $413.33 · Sale (S): 1,000 @ $970 · Option exercise (M): 1,000 @ $413.33 · Sale (S): 1,000 @ $965 · Option exercise (M): 1,000 @ $413.33 · Sale (S): 1,000 @ $960 · +4 more | EDGAR |
| 2024-02-12 | 4 | REGENERON PHARMACEUTICALS, INC. (REGN) | Option exercise (M): 500 @ $413.33 · Sale (S): 500 @ $945 · Option exercise (M): 500 @ $413.33 · Sale (S): 500 @ $955 · Option exercise (M): 500 (derivative) @ $0 · Option exercise (M): 500 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1225471 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →